Génétique moléculaire des cancers : dualité hôte-tumeur
作者： J. Robert
DOI: 10.1007/978-2-8178-0445-3_1
关键词:
摘要: Depuis que les outils de la biologie moleculaire et du sequencage ont ete accessibles pour l’identification biomarqueurs, biologistes pathologistes se sont focalises sur le genome tumoral, dont alterations responsables l’oncogenese progression des cancers, laissant aux epidemiologistes l’etude constitutionnel facteurs risque survenue cancers. L’oncologie offre en effet cette particularite d’offrir deux genomes distincts a chercheurs : patient celui tumeur qui, certes, derive premier mais apres avoir subi alterations, d’importance tres variable.
springer.com
sci-hub.st 参考文章(20)
Véronique Quillien, Élodie Vauléon, Stephan Saikali, Thierry Lesimple, Abderrahmane Hamlat, Amandine Etcheverry, Jean Mosser, Intérêt de la MGMT dans les gliomes Bulletin Du Cancer. ,vol. 98, pp. 291- 303 ,(2011) , 10.1684/BDC.2011.1332
William C. Hahn, Christopher M. Counter, Ante S. Lundberg, Roderick L. Beijersbergen, Mary W. Brooks, Robert A. Weinberg, Creation of human tumour cells with defined genetic elements Nature. ,vol. 400, pp. 464- 468 ,(1999) , 10.1038/22780
G. Delsol, Les anomalies moléculaires dans les lymphomes Bulletin Du Cancer. ,vol. 97, pp. 1347- 1364 ,(2010) , 10.1684/BDC.2010.1214
Yoshihisa Watanabe, Masato Maekawa, Methylation of DNA in Cancer Advances in Clinical Chemistry. ,vol. 52, pp. 145- 167 ,(2010) , 10.1016/S0065-2423(10)52006-7
Neal G. Copeland, Nancy A. Jenkins, Harnessing transposons for cancer gene discovery Nature Reviews Cancer. ,vol. 10, pp. 696- 706 ,(2010) , 10.1038/NRC2916
Allen D. Roses, Pharmacogenetics in drug discovery and development: a translational perspective Nature Reviews Drug Discovery. ,vol. 7, pp. 807- 817 ,(2008) , 10.1038/NRD2593
George A. Calin, Carlo M. Croce, MicroRNA signatures in human cancers Nature Reviews Cancer. ,vol. 6, pp. 857- 866 ,(2006) , 10.1038/NRC1997
L. D. Wood, D. W. Parsons, S. Jones, J. Lin, T. Sjoblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. Nikolskaya, Y. Nikolsky, R. Karchin, P. A. Wilson, J. S. Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. Shipitsin, J. K. V. Willson, S. Sukumar, K. Polyak, B. H. Park, C. L. Pethiyagoda, P. V. K. Pant, D. G. Ballinger, A. B. Sparks, J. Hartigan, D. R. Smith, E. Suh, N. Papadopoulos, P. Buckhaults, S. D. Markowitz, G. Parmigiani, K. W. Kinzler, V. E. Velculescu, B. Vogelstein, Genomic landscapes of human breast and colorectal cancers Science. ,vol. 318, pp. 1108- 1113 ,(2008) , 10.1126/SCIENCE.1145720
Yueyao Du, Qiong Zhou, Wenjin Yin, Liheng Zhou, Genhong Di, Zhenzhou Shen, Zhimin Shao, Jinsong Lu, The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures Breast Cancer Research and Treatment. ,vol. 129, pp. 839- 848 ,(2011) , 10.1007/S10549-011-1694-9
Frédéric Chibon, Pauline Lagarde, Sébastien Salas, Gaëlle Pérot, Véronique Brouste, Franck Tirode, Carlo Lucchesi, Aurélien de Reynies, Audrey Kauffmann, Binh Bui, Philippe Terrier, Sylvie Bonvalot, Axel Le Cesne, Dominique Vince-Ranchère, Jean-Yves Blay, Françoise Collin, Louis Guillou, Agnès Leroux, Jean-Michel Coindre, Alain Aurias, Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity Nature Medicine. ,vol. 16, pp. 781- 787 ,(2010) , 10.1038/NM.2174